Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients.

Journal of Clinical Microbiology
S K MurthyP B Michelsen

Abstract

This prospective study was designed to determine the incidence of rectal and/or oropharyngeal colonization rates of patients with Pseudomonas aeruginosa upon admission to a general hospital and the risk of becoming colonized while hospitalized. Consecutive 186 admissions (180 patients) to one medical ward, one surgical ward, and the intensive care unit were studied over a period of 5 months. Rectal and oropharyngeal swabs for P. aeruginosa were obtained on admission, weekly thereafter, and/or upon discharge. Forty-two patients (22.6%) were colonized on admission, 20 patients (10.8%) acquired P. aeruginosa during hospitalization. Colonization on admission was observed twice as frequently on the surgical ward and in the intensive care unit as on the medical ward. Positive rectal cultures were more frequent than oropharyngeal cultures throughout the study (P less than 0.01). For patients admitted culture positive or culture negative, the probabilities of remaining culture positive or culture negative, respectively, remained at 44 and 72% after 35 days of hospitalization. The most common P. aeruginosa serotypes were 1, 6, and 10, and pyocin types 1, 3, and 10 were predominant. There was no statistical difference in the serotypes or...Continue Reading

References

Apr 1, 1976·The American Journal of Medicine·M R Flick, L E Cluff
Nov 21, 1970·Lancet·E M CookeD R Martin
Nov 1, 1974·The Journal of Infectious Diseases·M L Tapper, D Armstrong
Nov 1, 1974·The Journal of Infectious Diseases·S C SchimpffP H Wiernik
Apr 1, 1966·The Journal of Pathology and Bacteriology·R R Gillies, J R Govan
Sep 1, 1966·The Journal of Trauma·J B Grogan
May 1, 1969·Journal of Bacteriology·M W FisherF J Gnabasik
Feb 1, 1969·Journal of Medical Microbiology·J R Govan, R R Gillies
Aug 1, 1970·Journal of Medical Microbiology·B J Stoodley, B T Thom
Nov 4, 1969·Journal of Medical Microbiology·A C Buck, E M Cooke
Aug 1, 1970·The American Journal of the Medical Sciences·G P Bodey
Sep 1, 1983·The Journal of Infectious Diseases·J V ConroyP E Griffin
Jul 1, 1981·The Journal of Infectious Diseases·V FainsteinG P Bodey
Sep 1, 1954·The Journal of Hygiene·E J LOWBURY, J FOX
Aug 29, 1959·Journal of the American Medical Association·M FINLANDM W BARNES
May 1, 1964·Journal of Clinical Pathology·J H DARRELL, A H WAHBA
Feb 1, 1955·Journal of Clinical Pathology·E J LOWBURY, A G COLLINS
Feb 1, 1951·Journal of Clinical Pathology·E J Lowbury

❮ Previous
Next ❯

Citations

Jan 1, 1994·Toxicon : Official Journal of the International Society on Toxinology·A L BaltchF Lutz
Jun 1, 1993·Epidemiology and Infection·G DöringC Wolz
Nov 1, 1989·Antimicrobial Agents and Chemotherapy·J E McGowanP L Parrott
Sep 25, 2009·Diagnostic Microbiology and Infectious Disease·Didier LepelletierStéphane Corvec
Feb 24, 2001·The Medical Clinics of North America·B A Cunha
Sep 7, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D LepelletierH Richet
Apr 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W KernG Döring
Jul 1, 1993·European Journal of Epidemiology·A GrigisT Barbui
Jan 30, 2020·Nature Communications·Kelly E R BachtaAlan R Hauser
Jul 19, 2000·Heart & Lung : the Journal of Critical Care·E L LarsonP Della Latta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.